untitled design

AstraZeneca reaches the mark of 2 billion doses distributed worldwide

Two billion doses of AstraZeneca-Oxford University’s Covid-19 vaccine have been provided worldwide, the Anglo-Swedish drugmaker and its partner said on Tuesday, in just under a year since its first approval.

The immunizer, which is the biggest contributor to the Covax vaccine-sharing scheme supported by the World Health Organization (WHO), is being made in 15 countries to supply more than 170, the companies said in a joint statement.

AstraZeneca in June of last year signed with the Serum Institute of India, the world’s largest vaccine maker by volume, to help double the vaccine’s manufacturing capacity to two billion doses.

The ChAdOx1 nCoV-19 injection, sold under the brands Vaxzevria and Covishield, faced challenges regarding efficacy data, supplies and links to rare blood clots.

AstraZeneca said last week that as the world learns to live with the coronavirus, which causes COVID-19, it will start making a modest profit from the injection after it has committed to selling it at cost during the pandemic.

The company’s CEO, Pascal Soriot, however, assured that low-income countries would continue to receive vaccines not for profit.

Reference: CNN Brasil

You may also like

Get the latest

Stay Informed: Get the Latest Updates and Insights

 

Most popular